ASKA Pharmaceutical Holdings Co., Ltd. (4886) Stock Statistics & Valuation Metrics

ASKA Pharmaceutical Holdings Co., Ltd. has a market cap or net worth of JPY 53.92B. The enterprise value is JPY 68.42B.

Market Cap

JPY 53.92B

Enterprise Value

JPY 68.42B

ASKA Pharmaceutical Holdings Co., Ltd. has 28,763,199 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

28,763,199

Owned by Insiders

―

Owned by Institutions

7.08%

ASKA Pharmaceutical Holdings Co., Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.05%.

Return on Equity (ROE)

0.08

Return on Assets (ROA)

0.05

Return on Invested Capital (ROIC)

5.05%

Return on Capital Employed (ROCE)

0.07

Revenue Per Employee

44.15M

Profits Per Employee

3.37M

Employee Count

1,611

Asset Turnover

0.63

Inventory Turnover

1.27

The current PE Ratio of ASKA Pharmaceutical Holdings Co., Ltd. is 11.71. ASKA Pharmaceutical Holdings Co., Ltd.’s PEG ratio is 1.30.

PE Ratio

11.71

PS Ratio

0.85

PB Ratio

0.83

Price to FCF

0.00

Price to Operating Cash Flow

0.00

PEG Ratio

1.30

In the last 12 months, ASKA Pharmaceutical Holdings Co., Ltd. had revenue of 71.13B and earned 5.42B in profits. Earnings per share was 191.10.

Revenue

71.13B

Gross Profit

34.15B

Operating Income

5.83B

Pretax Income

6.99B

Net Income

5.42B

EBITDA

8.75B

Earnings Per Share (EPS)

191.10

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow

0

Free Cash Flow

0

Free Cash Flow per Share

0.00

ASKA Pharmaceutical Holdings Co., Ltd. pays an annual dividend of JPY 28.00, resulting in a dividend yield of 3.21%

Dividend Per Share

JPY 28.00

Dividend Yield

3.21%

Payout Ratio

30.94%

Free Cash Flow Yield

0.00%

Earnings Yield

8.63%

Beta

0.35

52-Week Price Change

-0.78%

50-Day Moving Average

2040.56

200-Day Moving Average

2317.40

Relative Strength Index (RSI)

50.48

Average Volume (3m)

66.15K

ASKA Pharmaceutical Holdings Co., Ltd. upcoming earnings date is Feb 08, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 04, 2026

Next Earnings Date

Feb 08, 2027

Ex-Dividend Date

Mar 30, 2026

ASKA Pharmaceutical Holdings Co., Ltd. as a current ratio of 2.76, with Debt / Equity ratio of 16.34%

Current Ratio

2.76

Quick Ratio

1.45

Debt to Market Cap

0.17

Net Debt to EBITDA

0.15

Interest Coverage Ratio

26.28

In the past 12 months, ASKA Pharmaceutical Holdings Co., Ltd. has paid 1.37B in taxes.

Income Tax

1.37B

Effective Tax Rate

0.20

ASKA Pharmaceutical Holdings Co., Ltd. EV to EBITDA ratio is 8.38, with an EV/FCF ratio of 0.00.

EV to Sales

0.89

EV to EBITDA

8.38

EV to Free Cash Flow

0.00

EV to Operating Cash Flow

0.00

ASKA Pharmaceutical Holdings Co., Ltd. has JPY 7.11B in cash and marketable securities with JPY 11.84B in debt, giving a net cash position of -JPY 4.73B billion.

Cash & Marketable Securities

JPY 7.11B

Total Debt

JPY 11.84B

Net Cash

-JPY 4.73B

Net Cash Per Share

-JPY 164.34

Tangible Book Value Per Share

JPY 2,418.57

Gross margin is 47.50%, with operating margin of 8.28%, and net profit margin of 7.28%.

Gross Margin

47.50%

Operating Margin

8.28%

Pretax Margin

9.93%

Net Profit Margin

7.28%

EBITDA Margin

10.59%

EBIT Margin

8.29%

The average price target for ASKA Pharmaceutical Holdings Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

―

EPS Growth Forecast

9.04%

Smart Score

―

AI Score

69